Free News Archives
Latest Issue of OR Manager
February 2025

Estimates of COVID-19 infections in US healthcare workers

Editor's Note In this study, Johns Hopkins Medicine researchers used a computer model to predict the number of COVID-19 infections in US healthcare workers. The estimate was based on the number of healthcare workers in China and Italy, which experienced peaks in COVID-19 cases before the US. The researchers estimated…

Read More

By: Judy Mathias
December 17, 2020
Share

APIC urges healthcare workers, public to get vaccinated

Editor's Note Association for Professionals in Infection Control and Epidemiology (APIC) President Connie Steed, MSN, RN, CIC, FAPIC, on December 16, issued a statement urging healthcare workers and the public to get vaccinated with the COVI-19 vaccines when they are available. APIC supports the Centers for Disease Control and Prevention’s…

Read More

By: Judy Mathias
December 17, 2020
Share

Take our survey to win a gift card

Editor's Note The Kilmer Innovations in Packaging (KIIP) group seeks your feedback on sterile medical device packaging. This group is passionate about sterile packaging and its role in the delivery of sterile, safe-to-use medical devices. We invite you to take a brief survey for a chance to win a $50…

Read More

By: Judy Mathias
December 17, 2020
Share

Preop screening for COVID-19 in asymptomatic patients using chest CT, RT-PCR

Editor's Note This study from the Netherlands found that the added value of using chest CT in addition to RT-PCR to screen patients for COVID-19 before surgery was limited. Of 2,093 preoperative patients without COVID-19 symptoms analyzed, 1,224 were screened by CT and RT-PCR and 869 by chest CT only.…

Read More

By: Judy Mathias
December 15, 2020
Share

Pfizer/BioNTech vaccine reaches 141 of 145 first-day locations

Editor's Note The first batch of the Pfizer/BioNTech's newly authorized COVID-19 vaccine for emergency use reached 141 of 145 targeted locations on the first day of its national rollout, a Department of Health and Human Services spokeswoman told Reuters. Four island territories—American Samoa, Guam, North Mariana Islands, and the US…

Read More

By: Judy Mathias
December 15, 2020
Share

COVID-19 patient readmissions, mortality after initial hospital discharge

Editor's Note In this study of COVID-19 patients in the nationwide Veterans Affairs (VA) health care system, researchers from the University of Michigan, Ann Arbor, found that 27% of survivors of hospitalization were readmitted or died by 60 days after discharge. Of 2,179 index hospitalizations for COVID-19: 678 (31.1%) were…

Read More

By: Judy Mathias
December 15, 2020
Share

HHS purchases 100 million additional doses of Moderna’s COVID-19 vaccine

Editor's Note The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine. The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December…

Read More

By: Judy Mathias
December 15, 2020
Share

ICU nurse receives first Pfizer/BioNTech COVID-19 vaccine in US

Editor's Note After the Food and Drug Administration issued an Emergency Use Authorization for Pfizer/BioNTech’s COVID-19 vaccine on December 11, the company began shipping 2.9 million doses to 636 sites throughout the US. (https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19). On December 14, the first dose of the vaccine was administered at 9:23 am to an…

Read More

By: Judy Mathias
December 14, 2020
Share

Effect of intubation barrier devices on aerosol exposure

Editor's Note Barrier devices used for intubation may reduce operator exposure to infectious droplets and aerosols, but there is wide variation in aerosol containment, this study finds. Fully enclosed barrier devices reduced vapor and aerosol content in the area of the operator. If no barrier device was used, aerosol content…

Read More

By: Judy Mathias
December 14, 2020
Share

Safety, efficacy of BNT162b2 mRNA (Pfizer/BioNTech) COVID-19 vaccine

Editor's Note This study reports the safety and efficacy findings of the phase 2 and phase 3 parts of the clinical trial of the BNT162b2 mRNA (Pfizere/BioNTech) vaccine in preventing COVID-19 in persons 16 years of age or older. These results are the basis for an application for emergency use…

Read More

By: Judy Mathias
December 10, 2020
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat